Success Metrics

Clinical Success Rate

75.0%

Based on 3 completed trials

Completion Rate

75%(3/4)

Active Trials

0(0%)

Results Posted

67%(2 trials)

Terminated

1(14%)

Phase Distribution

Ph not_applicable

14%

Ph phase_2

29%

Ph phase_3

29%

Ph phase_4

29%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution7 total trials

Phase 2Efficacy & side effects

2(28.6%)

Phase 3Large-scale testing

2(28.6%)

Phase 4Post-market surveillance

2(28.6%)

N/ANon-phased studies

1(14.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

75.0%

3 of 4 finished

Non-Completion Rate

25.0%

1 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(2)

Completed(3)

Terminated(1)

Other(1)

Detailed Status

Completed3

Not yet recruiting1

Terminated1

Enrolling by invitation1

unknown1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

75.0%

Most Advanced

Phase 4

Trials by Phase

Phase 22 (28.6%)

Phase 32 (28.6%)

Phase 42 (28.6%)

N/A1 (14.3%)

Trials by Status

not_yet_recruiting114%

terminated114%

enrolling_by_invitation114%

unknown114%

completed343%

Recent Activity

0 active trials

Showing 5 of 7

not_yet_recruitingphase_2

MOTIF@FRESH: Modifying Organisms Transvaginally in Females @ FRESH

NCT07566754

enrolling_by_invitationphase_4

Surgiphor Us in TSA

NCT06601803

unknownphase_2

A Study to Evaluate the Pharmacodynamics, Pharmacokinetics, Safety, and Efficacy of UB-221 IV Infusion as an add-on Therapy in Patients With Chronic Spontaneous Urticaria

NCT05298215

terminatedphase_4

Seprafilm Slurry in the Prevention of Uterine Scarring in Patients Undergoing Hysteroscopic Myomectomy

NCT01632202

completedphase_3

Placebo-controlled RCT of Botulinum Toxin A as a Treatment for Provoked Vestibulodynia

NCT02773641

View all 7 trials

Clinical Trials (7)

Showing 7 of 7 trials

NCT07566754Phase 2

MOTIF@FRESH: Modifying Organisms Transvaginally in Females @ FRESH

Not Yet Recruiting

NCT06601803Phase 4

Surgiphor Us in TSA

Enrolling By Invitation

NCT05298215Phase 2

A Study to Evaluate the Pharmacodynamics, Pharmacokinetics, Safety, and Efficacy of UB-221 IV Infusion as an add-on Therapy in Patients With Chronic Spontaneous Urticaria

Unknown

NCT01632202Phase 4

Seprafilm Slurry in the Prevention of Uterine Scarring in Patients Undergoing Hysteroscopic Myomectomy

Terminated

NCT02773641Phase 3

Placebo-controlled RCT of Botulinum Toxin A as a Treatment for Provoked Vestibulodynia

Completed

NCT02375178Not Applicable

Antimicrobial Activity of Two Mouthwashes

Completed

NCT02165111Phase 3

Efficacy of Botulinum Toxin In Scleroderma-Associated Raynaud's Syndrome

Completed

All 7 trials loaded

Drug Details

Intervention Type: OTHER
Total Trials: 7